N-acetyl lysyltyrosylcysteine amide (ReNeurogen)

N/A

Report date: 2025/01/26 18:25:52

Base Information

Drug NameN-acetyl lysyltyrosylcysteine amide (ReNeurogen)
Drug Alias NameKYC (ReNeurogen)N-acetyl lysyltyrosylcysteine amideKYC
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionMyeloperoxidase inhibitors
TargetsMyeloperoxidase
Therapy Area/IndicationsAnemia, Sickle CellStrokeMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesReneurogen LLC
China Registration ClassN/A

Develop Information

Active CompaniesReneurogen LLC
Inactive CompaniesN/A
Active IndicationsAnemia, Sickle CellStrokeMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A